To meet the high demand for polymer-based nanoparticle drug delivery systems ARCI supplies novel, biocompatible polymers that provide encapsulation for difficult to solubilize drugs, sustained release, and selective delivery to target tissues and cells. Utilizing patented technology, including a new family of biocompatible and biodegradable block copolymers made from polyethylene glycol (PEG) and functionalized poly caprolactone (PCL), these ambiphilic compounds provide an excellent choice for linking molecules for drug delivery.

ARCI manufactures and markets these novel polymers under a service agreement with Meros Polymers Inc.